Research Article

Association of Biomarker Level with Cardiovascular Events: Results of a 4-Year Follow-Up Study

Table 1

Clinical characterization of patients in the no-outcome group and in the outcome group (composite endpoint) and with MACE.

VariablesTotal n = 267No outcome n = 224Composite end point n = 43MACE n = 15χ2 levelχ2 level

Sex, n (%)0.410.681.520.13
Female, n (%)175 (65.5)148 (66.1)27 (62.8)7 (46.7)
Male, n (%)92 (34.5)76 (33.9)16 (37.2)8 (53.8)
Age, years (Q25–Q75)54 (45–59)53 (44–58)56 (52–63)58.5 (53–61)3.23≤0.0011.820.069
30–44, n (%)62 (23.2)60 (26.8)2 (4.7)
45–59, n (%)141 (52.8)118 (52.7)23 (53.5)10 (66.7)
>60, n (%)64 (24.0)46 (20.5)18 (41.9)5 (33.3)
Educational background, n (%)0.670.500.390.70
Secondary and lower level, n (%)97 (36.3)85 (37.9)12 (27.9)6 (40.0)
Vocational secondary, n (%)119 (52.8)95 (42.4)24 (55.8)7 (46.7)
Higher, n (%)51 (24.0)44 (19.6)7 (16.3)2 (13.3)
Marital status, n (%)0.700.490.380.18
Married, n (%)174 (65.2)148 (66.1)26 (60.5)11 (73.3)
Not married, n (%)22 (8.2)18 (8.0)4 (9.3)1 (6.7)
Divorced/widowed, n (%)71 (26.6)54 (25.9)13 (30.2)3 (20.0)
Income level, n (%)1.080.281.330.18
Lower than middle and low, n (%)131 (49.1)111 (49.6)20 (46.5)6 (40.0)
Middle, n (%)91 (34.1)77 (34.4)14 (32.6)6 (40.0)
Above middle and high, n (%)33 (12.4)25 (11.2)8 (18.6)3 (20.0)
No answer, n (%)12 (4.5)11 (4.9)1 (2.3)
BMI, kg/m2, median (Q25–Q75)28.1 (24.8–32.3)28 (24.6–31)32.2 (25.5–38.6)30.3 (27–34)2.930.0031.910.056
Overweight (BMI 25–29.9 kg/m2), n (%)105 (39.3%)92 (41.1%)13 (30.2%)2 (13.3)
Obesity (BMI ≥ 30 kg/m2), n (%)91 (34.1%)66 (29.5%)25 (58.1%)10 (66.7)
Waist length, cm, median (Q25–Q75)96 (86–104)95 (86–103)108 (96–115)95.5 (85.2–108.7)2.260.0243.010.003
The presence of AO, n (%)195 (73%)160 (71.4%)35 (81.4%)14 (93.3)
SBP (mm hg), median (Q25–Q75)130 (120–140130 (117.5–140)140 (140–170)130 (120–150)2.280.0223.30≤0.001
DBP (mm hg), median (Q25–Q75)80 (80–90)80 (80–90)90 (80–100)80 (72–90)1.250.212.570.01
Smoking (%)30 (11.2)28 (12.5)2 (4.7)2 (13.3)1.490.140.090.93

χ2 and between the no-outcome group and outcome group with a composite endpoint; χ2 and between the no-outcome group and outcome group with a MACE.